---
layout: default
title: Alpha -Tocopherol Acetate Dl- Beta -Carotene Ascor
parent: 僅模型預測 (L5)
nav_order: 229
evidence_level: L5
indication_count: 0
---

# Alpha -Tocopherol Acetate Dl- Beta -Carotene Ascor
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multivitamin-Mineral Combination: Insufficient Data for Repurposing Evaluation

## One-Sentence Summary

This submission covers a 15-component multivitamin and mineral combination (including DL-α-Tocopherol Acetate, β-Carotene, Ascorbic Acid, Calcium Carbonate, Cholecalciferol, and 10 additional micronutrients).
The TxGNN model returned **no predicted indications** for this compound, likely because the combination as a whole cannot be resolved to a single DrugBank entity.
Without a prediction target, this candidate cannot proceed through standard repurposing evaluation.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not available (no regulatory record found) |
| Predicted New Indication | None — TxGNN returned no predictions |
| TxGNN Prediction Score | N/A |
| Evidence Level | N/A — no predictions generated |
| US Market Status | Not marketed in Taiwan |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

The TxGNN model operates on individual DrugBank-mapped compounds. This submission contains **15 active ingredients** submitted as a single semicolon-delimited string, which prevented the pipeline from resolving a DrugBank ID. Without a DrugBank anchor, the knowledge graph cannot generate repurposing candidates.

Each constituent ingredient (e.g., Ascorbic Acid → DrugBank DB00126; Cholecalciferol → DrugBank DB00169; Folic Acid → DrugBank DB00158) is individually mappable and may carry its own repurposing signal. However, the combination as a unit is not modelled.

To generate meaningful predictions, each ingredient should be submitted individually to the TxGNN pipeline.

---

## Safety Considerations

Please refer to the package insert for safety information.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The pipeline received a multi-ingredient combination string that could not be resolved to a single DrugBank entity, resulting in zero TxGNN predictions and no evaluable evidence. There is no basis for a repurposing recommendation at this time.

**To proceed, the following is needed:**

- **Decompose the combination**: Re-submit each of the 15 ingredients as separate Evidence Pack queries so that TxGNN can generate per-ingredient predictions.
- **Resolve DrugBank IDs**: Map each INN to its corresponding DrugBank ID before prediction; confirmed mappings exist for most of these micronutrients.
- **Identify intended original indication**: Clarify whether this combination was formulated for a specific clinical use (e.g., nutritional supplementation in a disease population, perioperative support, or a branded multivitamin) so that the original indication field can be populated.
- **Obtain MOA data**: Once individual DrugBank IDs are resolved, mechanism of action data will be retrievable and can support mechanistic plausibility analysis.
- **Regulatory check**: Run individual TFDA queries per ingredient to determine which components hold existing Taiwan licenses and whether a combination product has any prior regulatory history.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

